Ads
related to: MRNA Stock- Markets & Economy
View Our Latest Market Insights
and Get Economic Forecasts.
- Market Volatility
Insights on Current Conditions from
Our Investment Professionals.
- PracticeLab®
Resources to Help You Build Your
Business and Engage Your Clients.
- Guide to Recessions
9 Things You Need to Know to
Prepare for a Recession.
- Fixed Income Insights
View Our Latest Fixed Income
Investment Insights.
- Equity Insights
View Our Latest Equity
Investment Insights.
- Markets & Economy
Search results
Moderna (MRNA) Stock Moves -0.34%: What You Should Know
Zacks via Yahoo Finance· 1 day agoIn the latest trading session, Moderna (MRNA) closed at $103.44, marking a -0.34% move from the...
Vontobel Holding Ltd. Increases Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 1 day agoVontobel Holding Ltd. boosted its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 6.8% during the 4th quarter, according to its most recent 13F filing with ...
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
Zacks· 3 days agoFree Report) has been one of the most searched-for stocks on Zacks.com lately. Over the past month, shares of this biotechnology company have returned -0.4%, compared to the Zacks S&P 500 composite's ...
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) Director Sells $1,606,800.00 in Stock
ETF DAILY NEWS· 4 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the stock in a transaction on Wednesday, April 10th. The < ...
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Zacks via Yahoo Finance· 14 hours agoOver the past six months, shares of MRNA have risen 19.82%. (See the last biotech stock roundup...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 6 days agoIn a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold a...
Investing in Moderna (NASDAQ:MRNA) five years ago would have delivered you a 367% gain
Simply Wall St. via Yahoo Finance· 6 days agoFor many, the main point of investing in the stock market is to achieve spectacular returns. While...
Strategic Blueprint LLC Has $221,000 Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoStrategic Blueprint LLC cut its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.0% in the 4th quarter, according to its most recent filing with the Securities and ...
2 Stocks Down 30% to Buy Right Now
Motley Fool via Yahoo Finance· 5 days agoThe biotech stock is nearly 80% below its high set in mid-2021. Now for the good news: Moderna should have brighter days ahead. Do...the way. Moderna...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 4 days agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...
Ad
related to: MRNA Stock